IBEX Technologies (TSX.V: IBT) Update from CEO Paul Baehr

- Tweet0
- 0
- Pin It 0
- 0
- Subscribe to RSS
Subscribe

Subject: IBEX Technologies (TSX.V: IBT) Update from CEO Paul Baehr

ABOUT IBEX

IBEX manufactures and markets proteins for biomedical use through its wholly owned subsidiary IBEX Pharmaceuticals Inc. (Montréal, QC). IBEX Pharmaceuticals also manufactures and markets a series of arthritis assays, which are widely used in osteoarthritis research.

Click to Play

After our interviews, we host a Free-For-All session with the live participants to review all things Smallcap Discoveries is following, including updates and commentary companies from both the Select Portfolio and Select Watchlist.

Watch the FFA

86 East 23rd Ave, v5v 1w9, Vancouver, Canada

You may unsubscribe or change your contact details at any time.

Subscribe

Subject: IBEX Technologies (TSX.V: IBT) Update from CEO Paul Baehr